Samuel Seidu (MBChB, PGCME, MSc, MD, FRCGP, FRCP (Edin)) is Clinical Professor in Primary Care Diabetes and Cardio-metabolic Medicine at the University of Leicester, UK. He is currently the vice-chair for Research for Primary Care Diabetes Europe (PCDE). He is a board member of the Primary Care Diabetes Society of UK and is also currently a Clinical Lead and mentor for diabetes in the Leicester, Leicestershire and Rutland Integrated Care System. In 2021, he was named the most outstanding early career researcher by the Royal College of General Practitioners. He is a practicing Leicester City General Practitioner, a Partner, lead undergraduate tutor and GP trainer at the Hockley Farm Medical Practice and an associate editor of the Primary Care Diabetes journal.
His current research centres on (i) medication safety in diabetes and cardiometabolic diseases in the elderly population; (ii) quality improvement in diabetes care in primary care settings and (iii) addressing health inequalities in diabetes care. He is also working in the area of therapeutic inertia in people with diabetes to understand the causes, outcomes, and possible solutions.
Duality of Interest: Dr Seidu has received research support/grants from AstraZeneca, Janssen, Novo Nordisk, Servier, Sanofi and Takeda and speaker’s fees/honoraria from Abbot, Amgen, AstraZeneca, Eli Lilly, Janssen, MSD, Napp, Novo Nordisk, Sanofi and Takeda. He has also received payments for membership of boards/advisory panels from Abbot, Novartis, Janssen and Napp.
Date: Autumn 2022